Table 1 Main demographic and clinical data of PMR patients and controls.

From: An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica

 

PMR (n = 48)

MCVRF (n = 56)

p value

Sex (F/M)

28/20

30/26

0.626

Mean age, years (SD)

73.96 ± 6.89

71.63 ± 6.89

0.088

Mean disease duration, months (SD)

38.7 ± 32

40.3 ± 28

0.542

Cigarette smoking, n/%

8/16.7

16/28.6

0.151

Mean glucocorticoid daily dose, mg (SD)

7.05 ± 5

–

 

Mean cumulative glucocorticoid dose, mg (SD)

5946 ± 1537

–

 

Hypertension, n/%

25/52.1

31/55.4

0.738

Mean SBP, mmHg (SD)

135 ± 8

130 ± 8

0.03

Mean DBP, mmHg (SD)

81 ± 6

77 ± 5

0.437

Diabetes, n/%

9/18.8

9/16.1

0.719

Hypercholesterolemia, n/%

25/52.1

23/41.1

0.261

Mean BMI (SD)

26.1 ± 3.8

24.8 ± 3.1

0.214

Carotid artery stenosis, n/%

13/27.1

7/12.5

0.051

Mean ABI (SD)

1.10 ± 0.11

1.13 ± 1.10

0.228

  1. The p value in bold is the only statistically significant difference
  2. PMR polymyalgia rheumatica, MCVRF major cardiovascular risk factors, yrs years, SD standard deviation, SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, ABI ankle-brachial index.
Back to article page